Eisai Opens for Business in the Netherlands
Hatfield, England (ots/PRNewswire) - Eisai Europe Limited, a subsidiary of Eisai Co., Ltd announces the establishment of its sales and marketing operation in its wholly owned subsidiary in the Netherlands based in Amsterdam. The first Eisai product on the Dutch market is the epilepsy treatment Zonegran (zonisamide). Commenting on the opening of the new subsidiary, Eisai Netherlands Managing Director, Mr Gert-Jan ...